Patents by Inventor Paolo Roberto Pozzi

Paolo Roberto Pozzi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11844614
    Abstract: A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation.
    Type: Grant
    Filed: January 13, 2021
    Date of Patent: December 19, 2023
    Assignee: BIOSENSE WEBSTER (ISRAEL) LTD.
    Inventors: Carlo Pappone, Aharon Turgeman, Paolo Roberto Pozzi, Andrea Natalizia
  • Patent number: 11819281
    Abstract: A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation.
    Type: Grant
    Filed: January 11, 2021
    Date of Patent: November 21, 2023
    Assignee: BIOSENSE WEBSTER (ISRAEL) LTD.
    Inventors: Carlo Pappone, Aharon Turgeman, Paolo Roberto Pozzi, Andrea Natalizia
  • Publication number: 20210128245
    Abstract: A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation.
    Type: Application
    Filed: January 11, 2021
    Publication date: May 6, 2021
    Applicant: BIOSENSE WEBSTER (ISRAEL) LTD.
    Inventors: Carlo PAPPONE, Aharon TURGEMAN, Paolo Roberto POZZI, Andrea NATALIZIA
  • Publication number: 20210128043
    Abstract: A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation.
    Type: Application
    Filed: January 13, 2021
    Publication date: May 6, 2021
    Applicant: BIOSENSE WEBSTER (ISRAEL) LTD.
    Inventors: Carlo PAPPONE, Aharon TURGEMAN, Paolo Roberto POZZI, Andrea NATALIZIA
  • Patent number: 10952793
    Abstract: A system and method for improving ablation procedures is presented. The method may comprise measuring EGM signals; performing three dimensional mapping of the EGM signals; and detecting a location for ablation based on the mapping. The method may further comprise creating a potential duration map, a local activation time map, and a bipolar voltage map. The method may further comprise creating a PDM by defining a window of interest (WOI) comprising at least a cycle length; calculating previous heart beats based on the cycle length and reference annotation; and assigning the heart beats within the cycle length of the WOI to the WOI. The method may further comprise detecting a location for ablation by finding start and end potential durations for the WOI; calculating a potential duration value using the start and end potential durations; selecting an ablation point; and using the selected ablation point as the detected location.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: March 23, 2021
    Assignee: Biosense Webster (Israel) Ltd.
    Inventors: Carlo Pappone, Aharon Turgeman, Paolo Roberto Pozzi, Andrea Natalizia
  • Patent number: 10893819
    Abstract: A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation.
    Type: Grant
    Filed: December 26, 2017
    Date of Patent: January 19, 2021
    Assignee: Biosense Webster (Israel) Ltd.
    Inventors: Carlo Pappone, Aharon Turgeman, Paolo Roberto Pozzi, Andrea Natalizia
  • Patent number: 10888379
    Abstract: A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation.
    Type: Grant
    Filed: January 18, 2018
    Date of Patent: January 12, 2021
    Assignee: Biosense Webster (Israel) Ltd.
    Inventors: Carlo Pappone, Aharon Turgeman, Paolo Roberto Pozzi, Andrea Natalizia
  • Publication number: 20180206920
    Abstract: A system and method for improving ablation procedures is presented. The method may comprise measuring EGM signals; performing three dimensional mapping of the EGM signals; and detecting a location for ablation based on the mapping. The method may further comprise creating a potential duration map, a local activation time map, and a bipolar voltage map. The method may further comprise creating a PDM by defining a window of interest (WOI) comprising at least a cycle length; calculating previous heart beats based on the cycle length and reference annotation; and assigning the heart beats within the cycle length of the WOI to the WOI.
    Type: Application
    Filed: December 26, 2017
    Publication date: July 26, 2018
    Applicant: Biosense Webster (Israel) Ltd.
    Inventors: Carlo Pappone, Aharon Turgeman, Paolo Roberto Pozzi, Andrea Natalizia
  • Publication number: 20180206750
    Abstract: A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation.
    Type: Application
    Filed: December 26, 2017
    Publication date: July 26, 2018
    Applicant: Biosense Webster (Israel) Ltd.
    Inventors: Carlo Pappone, Aharon Turgeman, Paolo Roberto Pozzi, Andrea Natalizia
  • Publication number: 20180206921
    Abstract: A system and method for Brugada syndrome epicardial ablation comprising preparing an endocardial duration map; preparing a baseline epicardial duration map comprising at least one or more areas of delimination; and when some of the areas of delimination are greater than 200 ms, performing epicardial ablation of the areas of delimination greater than 200 ms. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not a BrS pattern appears in the updated epicardial duration map; and when the BrS pattern appears, performing epicardial ablation. The method may further comprise preparing an updated epicardial duration map after performing epicardial ablation, and determining whether or not an abnormal EGM exists in the updated epicardial duration map; and when the abnormal EGM exists, performing epicardial ablation.
    Type: Application
    Filed: January 18, 2018
    Publication date: July 26, 2018
    Applicant: Biosense Webster (Israel) Ltd.
    Inventors: Carlo Pappone, Aharon Turgeman, Paolo Roberto Pozzi, Andrea Natalizia